Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …

Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients
with cancer. Venous thromboembolism, which includes both deep vein thrombosis and …

Inflammation in the tumor microenvironment is positively correlated with cancer progression
and metastasis as well as the risk of thromboembolism in lung cancer patients. Here we …

Patients with cancer are at higher risk of atrial fibrillation (AF). Currently there are no
definitive data on clinical outcomes for nonvitamin K antagonist oral anticoagulant (NOACs) …

This paper aims to provide a narrative review of the risks, diagnosis, and management of
recurrent venous thromboembolism (VTE) in cancer patients. There is an established …

All cancers can increase the risk of developing venous thromboembolism (VTE), and
anticoagulants should be considered as an optimal treatment for patients suffering from …

Objective Venous thromboembolism is one of the most common cardiovascular disorders in
the any intensive care units (ICUs), which annually leads to death and imposes great costs …

Cancer patients are at increased risk for venous thromboembolism (VTE), which further
increases with advanced stages of malignancy, prolonged immobilization, or prior history of …

摘要目的探讨静脉血栓栓塞症(VTE) 对肺癌患者原发疾病诊疗方案的影响. 方法回顾性分析北京
大学肿瘤医院收治的肺癌患者中, 发生VTE 患者的临床资料. 计算肺癌患者VTE 的发生率 …

Genesis, Pathophysiology Management of Venous Diseases is the must-have resource on
venous disease. The book bridges the gap between basic science and clinical medicine …